Drug profile · INN
ticagrelor
BRILIQUE
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
ticagrelor (BRILIQUE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN ticagrelor
Brand BRILIQUE
Route ORAL
Formulation TABLET
ATC code B01AC24
Originator Amneal Pharma Europe Ltd
Related patents
Search patents →Frequently asked questions
What is ticagrelor?
ticagrelor (BRILIQUE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ticagrelor?
BRILIQUE is a marketed brand name for ticagrelor. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ticagrelor?
ticagrelor has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.